No copyright for AI-generated art, US judge rules

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

No copyright for AI-generated art, US judge rules

ai-image.jpg

Computer scientist Stephen Thaler sought copyright registration for an artwork created by one of his artificial intelligence programs

Artificial intelligence-generated works are not eligible for copyright protection, a US federal court ruled on Friday, August 18.

Computer scientist Stephen Thaler was appealing against the US Copyright Office’s refusal to register an image created by one of his inventions, an AI tool called the Creativity Machine.

In Friday’s judgment, the US District Court for the District of Columbia upheld the copyright registrar’s finding that human authorship is essential to a valid copyright claim.

The work in question was a visual image called 'A Recent Entrance to Paradise'. Thaler claimed the work had been created autonomously by the Creativity Machine with no human involvement.

Thaler and his legal team, led by Ryan Abbott, a law professor at the University of Surrey in the UK, have continuously argued that patent and copyright protection should be granted to AI-generated works and inventions.

So far, US courts and the USPTO have found that intellectual property rights should only be granted for works created by humans.

District Judge Beryl Howell took the same view in the latest case.

She also rejected Thaler’s arguments that the ownership of the registration for the AI-generated work, which would normally be granted to the author, should pass to him as the owner of the machine.

“These arguments concern to whom a valid copyright should have been registered, and in so doing put the cart before the horse.

“By denying registration, the [Copyright Office] concluded that no valid copyright had ever existed in a work generated absent human involvement, leaving nothing at all to register and thus no question as to whom that registration belonged,” Howell wrote.

Abbott confirmed on LinkedIn that Thaler’s team plans to appeal the judgment.

Thaler’s efforts to secure copyright registration are the latest evolution in a long-running campaign to reform IP laws around AI-generated works and inventions.

An appeal to name DABUS, one of Thaler’s other AI programs, as the inventor on two patent applications is pending at the UK Supreme Court. It heard the case in March.

The DABUS campaign has generated a series of high-profile appeals, including to the US Supreme Court, which rejected Thaler’s case.

So far, DABUS has only managed to be named as an inventor in South Africa, where the country’s IP office does not carry out substantive examination.

Appeals are currently pending at multiple other venues, including at Germany’s highest court, the Federal Court of Justice.

more from across site and SHARED ros bottom lb

More from across our site

Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Gift this article